Search Result "glycogensynthase kinase 3-beta"
Glycogen Synthase Kinase-3 Beta; A New Target in Pancreatic Cancer?
Journal: Current Cancer Drug Targets
Volume: 7 Issue: 3 Year: 2007 Page: 209-215
Author(s): G. Garcea, M. M. Manson, C. P. Neal, C. J. Pattenden, C. D. Sutton, A. R. Dennison, D. P. Berry
Strategies for the Design of Potent and Selective Kinase Inhibitors
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 1 Year: 2005 Page: 1845-1863
Author(s): Campbell McInnes, Peter M. Fischer
Progress in the Discovery of Polo-like Kinase Inhibitors
Journal: Current Topics in Medicinal Chemistry
Volume: 5 Issue: 2 Year: 2005 Page: 181-197
Author(s): Campbell McInnes, Mokdad Mezna, Peter M. Fischer
The Psychiatric Drug Lithium Increases DNA Damage and Decreases Cell Survival in MCF-7 and MDA-MB-231 Breast Cancer Cell Lines Expos ed to Ionizing Radiation
Journal: Current Molecular Pharmacology
Volume: 12 Issue: 4 Year: 2019 Page: 301-310
Author(s): Maryam Rouhani,Samira Ramshini,Maryam Omidi
Anti-inflammatory Potential of GSK-3 Inhibitors
Journal: Current Drug Targets
Volume: 22 Issue: 13 Year: 2021 Page: 1464-1476
Author(s): Chandi C. Kandar,Debanjan Sen,Arindam Maity
The Role of Glucose in the Pathogenesis of Alzheimers Disease Revisited:What Does it Tell us About the Therapeutic use of Lithium?
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 6 Issue: 3 Year: 2006 Page: 175-192
Author(s): Anna Strunecka, Paul Grof
Role of GSK-3 in the Regulation of Insulin Release and Glucose Metabolism
Ebook: Free Radical Biology of Endocrine, Metabolic & Immune Disorders
Volume: 1 Year: 2022
Author(s): Pallab Kanti Haldar,Himangshu Sekhar Maji,Ashok Kumar Balaraman
Doi: 10.2174/9789815049220122010006
GSK-3 Inhibitors in the Regulation and Control of Colon Carcinoma
Journal: Current Drug Targets
Volume: 22 Issue: 13 Year: 2021 Page: 1485-1495
Author(s): Sitansu S. Nanda,Md I. Hossain,Heongkyu Ju,Dong K. Yi,Georgia C. Papaefthymiou
Morpholine: Pharmacophore Modulating Pharmacokinetic Properties of Anticancer Leads
Ebook: Key Heterocyclic Cores for Smart Anticancer DrugâDesign Part II
Volume: 2 Year: 2022
Author(s):
Doi: 10.2174/9789815040043122020008